,14,26,64 Understanding the precise mechanisms by which different forms of phosphate impact on FGF23 expression and secretion may have implications for the development of therapeutic strategies targeting phosphate metabolism related disorders and associated bone disorders but may also lead to nutritional interventions to reduced inorganic phosphate intake. The gene discussed is FGF23; the disease is bone disorder.